Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease: A randomized trial with 2-year follow-up

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 10, 2000, Pages 1023-1032

  Bytzer, P ^a   Aalykke, C ^a   Rune, S ^a   Weywadt, L ^a   Gjorup, T ^a   Eriksen, J ^a   Bonnevie, O ^a   Bekker, C ^a   Kromann Andersen, H ^a   Kjaergaard, J ^a   Rask Madsen, J ^a   Vilien, M ^a   Hansen, J ^a   Justesen, T ^a   Vyberg, M ^a   Stubbe Teglbjaerg, P ^a   Havelund, T ^a   Lauritsen, K ^a   Staerk Laursen, L ^a   Avnstrom, S ^a   Skoubo Kristensen, E ^a   Andersen, I ^a   Nannestad Jorgensen, L ^a   Schulze, S ^a   Hasselstrom, J ^a   Bondesen, S ^a   Bremmelgaard, A ^a   Friis, S ^a   Draminsky Petersen, H ^a   Svendsen Jensen, F ^a   Kjaergard, B ^a   Ladefoged, K ^a   Holst Christensen, J ^a   Frederiksen, H J ^a   Jorgensen, P W ^a   Mertz Nielsen, A ^a   Hillingsoe, J ^a   Vestergaard, P ^a   Clemmensen Rotne, K ^a   Eskesen, G ^a   Petersen, R ^a   more..

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acid suppression; Dyspepsia; Eradication therapy; Helicobacter pylori; Reflux symptoms; Ulcer disease

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULCER HEALING;

EID: 0033773262     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200451135     Document Type: Article

References (26)

1. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxicillin with or without metronidazole
2. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers
3. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence
4. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
5. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 months' follow up
6. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
7. Prevention of duodenal ulcer relapse by long term treatment with omeprazole
8. Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: A randomized double-blind, placebo-controlled study
9. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux
10. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer
11. 13C-urea breath test for the detection of Helicobacter pylori
12. Transport conditions and number of biopsies necessary for culture of Helicobacter pylori
13. Gastric and duodenal infection caused by C. pyloridis: Histopathologic and microbiologic findings
14. Classification and grading of gastritis: The updated Sydney system
15. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease - A community-based study
16. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori
17. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: Impact of gastroesophageal reflux disease
18. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial
19. 2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: A prospective study
20. Continuous maintenance with low-dose lansoprazole versus H. pylori eradication in the prevention of duodenal ulcer recurrence
21. Prevalence of Helicobacter pylori in peptic ulcer patients in Great Rochester, NY: Is empirical triple therapy justified?
22. Prevalence of gastroesophageal reflux disease in H. pylori-positive peptic ulcer disease and the impact of eradication therapy
23. Does eradication of Helicobacter pylori influence the recurrence of symptoms in patients with symptomatic gastrooesophageal reflux disease? A randomised double blind study
24. No increase in reflux symptoms in patients with non-ulcer dyspepsia 12 months after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial
25. Symptoms of gastro-oesophageal reflux in duodenal ulcer patients after treatment for Helicobacter pylori during a two year follow-up
26. Does cure of Helicobacter pylori infection induce heartburn?